DNM1L and esophageal squamous cell carcinoma: In contrast, miR-203a-3p treatment effectively retarded mitochondrial outer membrane permeabilization and ATP depletion, suppressed ROS production in ESCC cells with Drp1 overexpression (Fig. 5E–G).